Bank of New York Mellon’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
Other funds holding ACER
YCM
NCM
HF
VF
HAIM
Bank of New York Mellon's ACER Position: Q3 2023 in Review
Bank of New York Mellon sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 10,290 shares — an estimated $9.5K sold.
Bank of New York Mellon first reported a position in ACER in Q2 2017 and held it in 18 quarters. The position peaked at $47K in Q2 2020. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.
- Bank of New York Mellon reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
- Bank of New York Mellon sold 10,290 Acer Therapeutics Inc shares in Q3 2023, an estimated $9.5K.
- Bank of New York Mellon first reported a position in Acer Therapeutics Inc in Q2 2017 and held it in 18 quarters.
- Bank of New York Mellon's Acer Therapeutics Inc position peaked at $47K in Q2 2020.
- 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.
Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.